← back to search

Boris Guennewig

The University of Sydney · AU
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA Research and Splicing, MicroRNA in disease regulation, Alzheimer's disease research and treatments, and Neuroinflammation and Neurodegeneration Mechanisms.
h-index
20
citations
1,291
works
48
NIH funding
primary concept
email

Recent publications

Future-proofing genomic data and consent management: a comprehensive review of technology innovations
GigaScience 2024cited by 26position: middledoi
Machine learning analysis of the UK Biobank reveals prognostic and diagnostic immune biomarkers for polyneuropathy and neuropathic pain in diabetes
Diabetes Research and Clinical Practice 2023cited by 21position: middledoi
Ranking the risk factors for Alzheimer’s disease; findings from the UK Biobank study
Aging Brain 2023cited by 16position: middledoi
The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
Journal of Neuroinflammation 2022cited by 80position: middledoi
Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
Scientific Reports 2021cited by 61position: firstdoi
The acute phase protein lactoferrin is a key feature of Alzheimer’s disease and predictor of Aβ burden through induction of APP amyloidogenic processing
Molecular Psychiatry 2021cited by 50position: middledoi
New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis
Translational Neurodegeneration 2021cited by 40position: lastdoi
A regulatory T cell Notch4–GDF15 axis licenses tissue inflammation in asthma
Nature Immunology 2020cited by 114position: middledoi
Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
Nature Neuroscience 2018cited by 106position: middledoi
THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders
Translational Psychiatry 2018cited by 45position: firstdoi
Schizophrenia hiPSC neurons display expression changes that are enriched for disease risk variants and a blunted activity-dependent response
bioRxiv (Cold Spring Harbor Laboratory) 2016cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andrew N. McCorkindale · Garvan Institute of Medical Research4 papers (2021–2023)Greg T. Sutherland · The University of Sydney3 papers (2021–2023)Phillip K. West · The University of Sydney2 papers (2021–2022)Ellis Patrick · The University of Sydney2 papers (2021–2021)Antony A. Cooper · Garvan Institute of Medical Research2 papers (2018–2021)Paul J. Austin · UNSW Sydney2 papers (2023–2023)Michael Allwright · The University of Sydney2 papers (2023–2023)Guy Barry · QIMR Berghofer Medical Research Institute2 papers (2016–2018)Dominik C. Kaczorowski · South Australia Pathology2 papers (2016–2018)Kristen Brennand · Allen Institute for Brain Science2 papers (2016–2018)Panos Roussos · Institute of Genetics2 papers (2016–2018) · 1 papers (2021–2021)Samuel Brennan · University of Technology Sydney1 papers (2021–2021) · 1 papers (2020–2020)Peter T. Nelson · University of Kentucky1 papers (2018–2018) · 1 papers (2020–2020)Kosar Hooshmand · The University of Sydney1 papers (2021–2021)Joseph J. Locascio · Harvard University1 papers (2018–2018)John S. Mattick · UNSW Sydney1 papers (2018–2018) · 1 papers (2020–2020)